Fair Value Measurements (Tables)

12 Months Ended

Jun. 30, 2016

Fair Value Disclosures [Abstract]

Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]

Unobservable Input	February 10, 2016	June 30, 2016
Risk free rate	1%	1%
Revenue Volatility	25%	25%
Projected period of payment	Approximately 3 years	Approximately 3 years

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

(dollars in millions)	Fair Value
Balance at June 30, 2014	$	5.2
Additions of contingent consideration from ClinIntel acquisition	9.9
Change in fair value of contingent consideration	(7.4		)
Effect of changes in exchange rates used for translation	(0.4		)
Balance at June 30, 2015	7.3
Additions of contingent consideration from Health Advances acquisition	4.5
Change in fair value of contingent consideration	8.7
Payment of contingent consideration	(14.1		)
Effect of changes in exchange rates used for translation	(1.2		)
Balance at June 30, 2016	$	5.2

Fair Value Hierarchy By Level

(dollars in millions)	Level 1		Level 2			Level 3			Total
Contingent Consideration	$	—	$	—		$	(5.2	)	$	(5.2	)
Interest Rate Derivative Instruments	—		(1.3		)	—			(1.3		)
Foreign Currency Exchange Contracts	—		(5.3		)	—			(5.3		)
Total	$	—	$	(6.6	)	$	(5.2	)	$	(11.8	)

The following table sets forth by level, within the fair value hierarchy, our assets (liabilities) carried at fair value as of June 30, 2015:

(dollars in millions)	Level 1		Level 2			Level 3			Total
Contingent Consideration	$	—	$	—		$	(7.3	)	$	(7.3	)
Interest Rate Derivative Instruments	—		0.7			—			0.7
Foreign Currency Exchange Contracts	—		(5.6		)	—			(5.6		)
Total	$	—	$	(4.9	)	$	(7.3	)	$	(12.2	)